Artificial Lung – New Medical Devices For Tracking Lung Cancer Deeply

Artificial Lung

PUNE, MAHARASHTRA, INDIA, February 27, 2018 /EINPresswire.com/ — WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Artificial Lung – Medical Devices Pipeline Assessment, 2018”

Artificial Lung

Overview:

Medical Devices sector report, “Artificial Lung – Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Lung pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by team of experts.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3010453-artificial-lung-medical-devices-pipeline-assessment-2018

Major Key Players are:

ALung Technologies Inc

Breethe, Inc.

Case Western Reserve University

Haemair Ltd

Lung Biotechnology PBC

McGowan Institute for Regenerative Medicine

MedArray Inc.

The Charles Stark Draper Laboratory Inc

University of California San Francisco

University of Michigan

University of Pittsburgh

Xenios AG

Major Scope Of the Report:

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.

The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects.

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. 

The report provides key clinical trial data of ongoing trials specific to pipeline products. 

Recent developments in the segment / industry.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Artificial Lung Overview 6

3 Products under Development 7

3.1 Artificial Lung – Pipeline Products by Stage of Development 7

3.2 Artificial Lung – Pipeline Products by Territory 8

3.3 Artificial Lung – Pipeline Products by Regulatory Path 9

3.4 Artificial Lung – Pipeline Products by Estimated Approval Date 10

3.5 Artificial Lung – Ongoing Clinical Trials 11

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3010453-artificial-lung-medical-devices-pipeline-assessment-2018

 

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Respiratory Assist Devices – Market To Witness Exponential Growth By 2025

Respiratory Assist Devices

PUNE, MAHARASHTRA, INDIA, February 27, 2018 /EINPresswire.com/ — WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2018”

Respiratory Assist Devices

Overview:

Medical Devices sector report, “Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2018" provides an overview of Respiratory Assist Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Respiratory Assist Devices pipeline products.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3010451-Respiratory Assist Devices-medical-devices-pipeline-assessment-2018

Major Key Players are:

ALung Technologies Inc

Breethe, Inc.

Case Western Reserve University

enmodes GmbH

Haemair Ltd

Liberate Medical, LLC

Lung Biotechnology PBC

McGowan Institute for Regenerative Medicine

Pneumedicare Ltd.

Rice University

The Charles Stark Draper Laboratory Inc

Major Scope Of the Report:

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.

The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects.

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. 

The report provides key clinical trial data of ongoing trials specific to pipeline products. 

Recent developments in the segment / industry.

Table of Contents

Table 1: Respiratory Assist Devices – Pipeline Products by Stage of Development 7

Table 2: Respiratory Assist Devices – Pipeline Products by Segment 8

Table 3: Respiratory Assist Devices – Pipeline Products by Territory 9

Table 4: Respiratory Assist Devices – Pipeline Products by Regulatory Path 10

Table 5: Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 11

Table 6: Respiratory Assist Devices – Ongoing Clinical Trials 12

Table 7: Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 13

Table 8: Respiratory Assist Devices – Pipeline Products by Stage of Development 14

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3010451-Respiratory Assist Devices-medical-devices-pipeline-assessment-2018

 

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Nebulizers Market by Medical Device and Ongoing Clinical Trials 2018

Nebulizers

PUNE, MAHARASHTRA, INDIA, February 27, 2018 /EINPresswire.com/ — Nebulizers

Overview:

Medical Devices sector report, “Nebulizers – Medical Devices Pipeline Assessment, 2018" provides an overview of Nebulizers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nebulizers pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3010451-nebulizers-medical-devices-pipeline-assessment-2018

Major Key Players are:

Aura Medical

Baby's Breath Ltd.

Creare Inc

DesignWise Medical Inc (Inactive)

Marquette University

Parion Sciences Inc

SolAeroMed Inc

Stirling Pharma Inc

University of California San Diego

Major Scope Of the Report:

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.

The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects.

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. 

The report provides key clinical trial data of ongoing trials specific to pipeline products. 

Recent developments in the segment/industry.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Nebulizers Overview 7

3 Products under Development 8

3.1 Nebulizers – Pipeline Products by Stage of Development 8

3.2 Nebulizers – Pipeline Products by Segment 9

3.3 Nebulizers – Pipeline Products by Territory 10

3.4 Nebulizers – Pipeline Products by Regulatory Path 11

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3010451-nebulizers-medical-devices-pipeline-assessment-2018

 About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

MatriSys Bioscience Announces Additions to our Scientific Advisory Board

MatriSys Bioscience's Scientific Advisory Board will be joined by three independent, internationally renowned scientists and clinicians

LA JOLLA, CALIFORNIA, USA, February 27, 2018 /EINPresswire.com/ — MatriSys Bioscience, a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, today announced additions to its Scientific Advisory Board (SAB). MatriSys Bioscience's co-founder, Professor Richard Gallo, Distinguished Professor and Founding Chair of the Department of Dermatology at UCSD and a world leader in the use of microbes as novel medicine will be joined by three independent, internationally renowned scientists and clinicians.

Dr. Lawrence Eichenfield is Professor of Dermatology and Pediatrics, Vice Chair, Department of Dermatology and Chief, Pediatric and Adolescent Dermatology at Rady Children's Hospital, San Diego and at the University of California, San Diego School of Medicine. He earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children's Hospital of Philadelphia before completing dermatology training at the Hospital of the University of Pennsylvania. He is board certified in pediatrics, dermatology, and pediatric dermatology.
Dr. Eichenfield's clinical interests include atopic dermatitis, acne, psoriasis, vascular lesions, neonatal dermatology, laser surgery, and skin signs of systemic disease. He has authored more than 300 journal articles, chapters, abstracts and books on these topics and serves on the editorial boards of several journals and periodicals. Along with being editor-in-chief of Pediatric Dermatology, he has served as senior editor for "Neonatal and Infant Dermatology" and "The Eczemas".
Dr. Eichenfield is past president of the Society for Pediatric Dermatology and has served on the board of the American Academy of Dermatology. He is also a founding board member of the American Acne & Rosacea Society and is a founder and co-chair of the Pediatric Dermatology Research Alliance, a collaborative research network.

Dr. Peter Elias is Professor Emeritus in the Department of Dermatology at the University of California, San Francisco where he serves as the Vice-Chairman of the Department of Dermatology and heads a multidisciplinary research group headquartered at the SF Veteran Affair Medical Center.

Dr. Elias received his medical degree from the University of California, San Francisco. He trained in dermatology at Harvard University and NIH, and in internal medicine at UCSF. Dr. Elias has devoted his research to understanding epidermal biology, focusing primarily on the skin's permeability barrier and its other protective functions. His research is aimed at improving the care of dermatology patients through a better understanding of disease-causing mechanisms and the development of novel therapies with improved safety profiles. He has co-authored over 700 scientific articles and review articles, and three books on the subject of the skin barrier in health and disease.

Dr. Elias has served or currently serves as a consultant to several pharmaceutical and cosmetic industries including J&J, Unilever, Estée Lauder, CHANEL (MAB), L'Oréal, ISDIN (MAB), and Symrise (SAB), and currently to PuraCap Pharma (MAB), Pharmavite (MAB), NeoPharma (SAB), GPower, Patagonia, and Avadim (SAB).

He is the recipient of many honors, including the William Montagna and the Kligman-Frost Awards from the Society of Investigative Dermatology. He is an honorary member of the SID and has been elected to memberships in the American Society for Clinical Investigation and the American Association of Professors.

Dr. Amy Paller is Professor and Chair of Dermatology, Professor of Pediatrics, and Director of Northwestern University Feinberg School of Medicine's Skin Disease Research Center. Dr. Paller is an NIH-funded investigator who currently serves on the NIAMS Board of Scientific Counselors (NIH). Dr. Paller has been President of the Society for Investigative Dermatology, the Women's Dermatologic Society, and the Society for Pediatric Dermatology, and currently is President of the International Eczema Council and the International Society of Pediatric Dermatology. She was the inaugural Co-chair of the Pediatric Dermatology Research Alliance and has been Chair of the Scientific Advisory Board of the National Eczema Association.
Dr. Paller's clinical interests focus on genetic disorders of the skin and cutaneous immunologic disorders in children, including atopic dermatitis. In her laboratory, she studies the role of topically-applied gene suppression using nanoconstructs to treat skin disease with a focus on inflammatory skin disease and diabetic ulcers. Dr. Paller has been the lead investigator on several landmark trials in pediatric skin disease. She is an author of more than 550 journal articles, chapters, and books, and has been on the editorial boards of several journals, including the Journal of Investigative Dermatology and the Journal of the American Academy of Dermatology. She is the recipient of many awards, among them the Rothman Award from the Society for Investigative Dermatology.

On welcoming the members to the SAB, Mark S. Wilson, MatriSys Bioscience's CEO said: "Growing our Scientific Advisory Board represents another important step forward for the company. We have attracted some of the world's leading experts in dermatological diseases as we pursue the development of MSB-01. Importantly, the additions to our SAB are an endorsement of the Company's unique technology platform. These new SAB members bring a wealth of experience across research and clinical trials which will be essential to drive forward the clinical potential of our unique skin microbiome platform for key dermatological indications for which effective therapies are currently limited."

The Scientific Advisory Board will work closely with the MatriSys management team as it actively prepares to advance its lead product candidate, MSB-01, a microbiome-based topical formulation into Phase II B clinical studies. The Company believes MSB-01 has the potential to transform the treatment of atopic dermatitis for the eighteen million American patients.

About MSB-01

MatriSys Bioscience is currently developing MSB-01 which is a commercially viable room-temperature stable topical formulation of freeze-dried S. hominis Strain A9 bacteria in an anhydrous lotion for application to the lesional skin of AD patients. The lyophilized bacteria are revived in the presence of skin moisture and kill S. aureus that colonize the patients' skin. MSB-01 entered Phase 2A in September 2017 (in a frozen formulation).

About MatriSys Bioscience

MatriSys Bioscience is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five dermatology and skin care conditions. Our foundational microbiome therapeutics platform is based on the pioneering work of Richard L. Gallo MD PhD.

Mark S. Wilson
MatriSys Bioscience, Inc.
858.456.3919
email us here


Source: EIN Presswire

San Francisco, California Doctor Selected to the "America's Best Physicians" 2018 Directory

Dr. Ella G. Faktorovich

Dr. Ella G. Faktorovich, MD listed as Top Doctor in Ophthalmology & Eye Surgery

Dr. Ella G. Faktorovich Selected as Top Doctor in Ophthalmology & Eye Surgery”

— TodaysBestPhysicians.com

SAN FRANCISCO , CALIFORNIA, UNITED STATES, February 26, 2018 /EINPresswire.com/ — San Francisco, California doctor, Dr. Ella G. Faktorovich has been selected to the "America's Best Physicians" registry for 2018. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Faktorovich practices Ophthalmology at 505 Beach Street, Suite 110 in San Francisco serving patients in San Francisco, Marin, Peninsula and surrounding areas.

Services include: Refractive surgery, Laser Vision Correction, LASIK, Photorefractive keratectomy (PRK), Advanced Cataract Surgery, Transplants, Collagen Cross-Linking, Corneal and Presbyopia Surgery.

Dr. Ella G. Faktorovich graduated Phi Beta Kappa from UC Berkeley. She received her Medical Degree with honors from University of California, San Francisco (UCSF) School of Medicine. She completed her Ophthalmology Residency at UCSF Department of Ophthalmology. She then received two years of advanced training in Laser and Refractive Surgery at the Jules Stein Eye Institute, UCLA School of Medicine.

Dr. Faktorovich has received numerous honors and completed award-winning research. She has published numerous articles, book chapters and abstracts and has lectured extensively. Dr. Faktorovich is the Founder and Chairman of the annual San Francisco Cornea, Cataract, and Refractive Surgery Symposium and the Pacific Vision Institute Research Foundation. She continues to teach Advanced Surgical Techniques to her peers and lecture worldwide.

Dr. Ella G. Faktorovich is a member of American Academy of Ophthalmology, California Medical Association, San Francisco Medical Society, Association for Research in Vision and Ophthalmology, International Society of Refractive Surgery and the American Society of Cataract and Refractive Surgery. She is Board Certified and has earned Fellowship status by the American Board of Ophthalmology. Dr. Faktorovich has been in practice for over 20 years.

For more information, please go to www.TodaysBestPhysicians.com or contact Dr. Ella G. Faktorovich, MD directly at 415-922-9500.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Doctors were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Doctors that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Physicians" directory.

TodaysBestPhysicians.com
Americas Best Physicians
5555555555
email us here


Source: EIN Presswire

World Human Albumin Industry: 2018 Market Size, Share, Uses, Applications, Key Manufacturers and 2025 Demand Forecast

Human Albumin Market 2018

Global Human Albumin Market Research Report 2018

Latest research report on “Global Human Albumin Market 2018 Research Report ” now available at a high quality database of OrianResearch.com

PUNE, MAHARASHTRA, INDIA, February 26, 2018 /EINPresswire.com/ — The Global Human Albumin Market was valued at USD XX million in 2017 and is expected to be valued at USD XX Billion by 2025, at a CAGR of XX % during the forecast period. The growth of the Global Human Albumin Market is largely driven by the continuous research and development in albumin which led to many therapeutic as well as non-therapeutic applications such as stabilizing Alzheimers disease.

Get Sample Copy of this Report at – https://www.orianresearch.com/request-sample/461019 .

Global Human Albumin Market is segmented by Application and Region.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Complete report on Human Albumin Industry spread across 119 pages, profiling 07 companies and supported with tables and figures. Enquire for more at – https://www.orianresearch.com/enquiry-before-buying/461019 .

Top Key Companies Analyzed in Global Human Albumin Market are –
• CSL Behring
• Baxalta
• Kedrion
• Grifols
• Octapharma AG
• Biotest
• Green cross

Key benefit of this report:
• This report provides current market trends and future growth expectations.
• This report examines the market size and changing competitive dynamics
• It covers information regarding key drivers, challenges or restraining market growth
• Market factor analysis delivers treasured information regarding the possible purchasers and suppliers and understanding the stakeholders involved.
• This report incorporates data regarding companies and business decision by having complete insights on the markets and by creating in depth analysis of market segments.

Target Audience
• Albumin product developers
• Hospitals and Research Laboratories
• Pharmaceutical and biotechnology companies
• Distributors and suppliers
• Government organizations

Get Direct Copy of this Report @ https://www.orianresearch.com/checkout/461019 .

Major Points Covered in Table of Contents:
1. Executive Summary
2. Demographic Overview
3. Research Methodology
4. Premium Insights
5. Market Overview
6. Market Factor Analysis
7 Global Human Albumin Market By Application
8 Global Human Albumin Market By Region
9 Market Trends & Competitive Analysis
10 Company Profiles
Author List
Disclosure Section
Research Methodology
Data Source

Ruwin Mendez
OrianResearch Consultants
+1 832-380-8827
email us here


Source: EIN Presswire

Spotswood, New Jersey Dentist Selected to the "America's Best Dentists" 2018 Directory

Dr. Matthew Sorkin

Dr. Matthew Sorkin, DDS, FAGD Listed as Top Dentist in Family, Cosmetic, Implant & Sedation Dentistry

Dr. Matthew Sorkin Selected as Top Dentist in Family, Cosmetic, Implant & Sedation Dentistry”

— TodaysBestDentists.com

SPOTSWOOD , NEW JERSEY , UNITED STATES, February 26, 2018 /EINPresswire.com/ — Spotswood, New Jersey dentist, Dr. Matthew Sorkin has been selected to the "America's Best Dentists" registry for 2018. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Sorkin practices Family, Cosmetic, Implant & Sedation Dentistry at 418 Main St. in Spotswood serving patients in Monroe Twp. Helmetta, Old Bridge, Spotswood, and East Brunswick.

Services include: Cosmetic Dentistry, Dental Implants, Planscan/E4D Same Day Crowns, Air-Brush No-Drill Fillings, Laser Gum Therapy, Oral Sedation Dentistry, Root Canal Treatment, Tooth Colored Fillings, and Teeth Whitening.

Dr. Sorkin received his doctorate of dental surgery degree (DDS) from Columbia University School of Dental Medicine. He then performed a General Practice Residency at Hackensack University Medical Center. He continues to be quite active in postgraduate education earning him Fellowship Status in the Academy of General Dentistry.

Dr. Matthew Sorkin is a member of the American Dental Association, New Jersey Dental Association and Middlesex County Dental Society. During his 25 years in practice Dr. Sorkin has become well-known for providing highly personal, state-of-the-art care at the highest level.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Matthew Sorkin, DDS directly at 732-723-5100 or www.caringdentalspotswood.com.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
5555555555
email us here


Source: EIN Presswire

Palm Beach, Florida Dentist Selected to the "America's Best Dentists" 2018 Directory

Dr. Mitchell Josephs

Dr. Mitchell Josephs, DDS listed as Top Dentist in Cosmetic & Implant Dentistry

Dr. Mitchell Josephs Selected as Top Dentist in Aesthetic & Implant Dentistry”

— TodaysBestDentists.com

PALM BEACH, FLORIDA , UNITED STATES, February 26, 2018 /EINPresswire.com/ — Palm Beach, Florida dentist, Dr. Mitchell Josephs has been selected to the "America's Best Dentists" registry for 2018. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Josephs practices Cosmetic & Implant Dentistry at 44 Cocoanut Row in Palm Beach serving patients in Palm Beach County FL, West Palm Beach, Jupiter, Palm Beach Gardens, Boca Raton, Wellington, Palm Beach, Juno Beach, Lake Worth, Boynton Beach, Manalapan and South Palm Beach.

Services include: Aesthetic Dentistry, Veneers, Implants, Complex Crowns and Bridge Reconstruction, Prosthodontics and Tooth Whitening.

Dr. Josephs received his Doctorate of Dental surgery degree (DDS) from McGill University in 1988. He then completed his residency at Beth Israel Medical Center in New York. Dr. Josephs was the first Dentist appointed to the staff at JFK Medical Center. He is a Faculty Advisory Board member at McGill University’s Faculty of Dentistry.

Dr. Josephs has had articles published in New York Times, Glamour Magazine, Men’s Health and Muscle and Fitness. In addition, he has had TV appearances on News 12 Westchester ‘Morning Addition’, News 12 Connecticut’s ‘The Exchange’, South Florida’s WPEC Channel 12 and WPTV Channel 5. For years, he hosted the popular “Tooth Talk” segment WBZT 1230.

Dr. Josephs is well-known for providing the highest level of care in aesthetic and implant dentistry; combining state-of-the-art technology, innovative techniques and personalized, individualized treatment for his patients. He is a member of American Academy of Implant Dentistry, American Academy of Cosmetic Dentistry, Academy of General Dentistry, American Dental Association and Florida Dental Association. Dr. Josephs has been in practice for 30 years.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Mitchell Josephs, DDS directly at 561-832-4675 or www.palmbeachdentist.com.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
5555555555
email us here


Source: EIN Presswire

New City, New York Dentist Selected to the "America's Best Dentists" 2018 Directory

Dr. Michael Rothstein

Dr. Michael Rothstein, DDS Listed as Top Dentist in Cosmetic, Family & Implant Dentistry

Dr. Michael Rothstein Selected as Top Dentist in Cosmetic, Family & Implant Dentistry”

— TodaysBestDentists.com

NEW CITY, NEW YORK , UNITED STATES, February 26, 2018 /EINPresswire.com/ — New City, New York dentist, Dr. Michael Rothstein has been selected to the "America's Best Dentists" registry for 2018. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Rothstein practices Cosmetic, Family & Implant Dentistry at 16 Squadron Blvd, Suite 105 in New City, serving patients in Rockland County and throughout the Tri-State Area.

Services include: Aesthetic Dentistry, All Phases of Restorative Dentistry including Crowns, Bridges, Dentures and Fillings, Dental Implants, Periodontics (Gum Treatments), Oral Surgery, Endodontics (Root Canals), Cerec Digital Dentistry, Gingival Laser Surgery, 3-D Imaging and Zoom Whitening.

Dr. Michael Rothstein received his Doctorate in Dental Surgery degree from Stonybrook University in 1994. He performed a General Practice Residency at The Bronx VA Medical Center. He then went on to complete his Specialty Residency Training in Prosthodontics at the Manhattan VA Medical Center.

Dr Rothstein has served as a Cerec Dentistry Clinical Mentor/Instructor and Clinical Instructor New York University School of Dentistry. During his 24 years in practice, the doctor has remained active in continuing education and is at the forefront of state-of-the-art dental techniques.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Michael Rothstein, DDS directly at 845-634-8866 or www.Rothsteindentistry.com.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
5555555555
email us here


Source: EIN Presswire

Brazil Ostomy Procedures – New Report Exlopre Market Modeling and Forecasting till 2024

Brazil Ostomy

PUNE, MAHARASHTRA, INDIA, February 26, 2018 /EINPresswire.com/ —

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Brazil Ostomy Procedures Outlook to 2024”

Brazil Ostomy

Overview

Brazil Ostomy Procedures Outlook to 2024, provides key procedures data on the Brazil Ostomy Procedures. The report provides procedure volumes within market segments – Conventional Colostomy Procedures, Conventional Ileostomy Procedures and Conventional Urostomy Procedures.

The data in the report is derived from dynamic market forecast models. This report is epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2456993-brazil-ostomy-procedures-outlook-to-2024

 

Synopsis

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies.

Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

Brazil Ostomy Procedures volumes by segments – Conventional Colostomy Procedures, Conventional Ileostomy Procedures and Conventional Urostomy Procedures. 

Projections for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.

Brazil Ostomy Procedures Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Ostomy Procedures, Segmentation 4

2.3 Definitions of Procedures Covered in the Report 4

3 Ostomy Procedures, Brazil 5

3.1 Ostomy Procedures, Brazil, 2010-2017 5

3.2 Ostomy Procedures, Brazil, 2017-2024 7

4 Appendix 9

4.1 Research Methodology 10

4.1.1 Coverage 10

4.1.2 Secondary Research 10

4.1.3 Primary Research 11

4.1.4 Market Modeling and Forecasting 12

4.1.5 Company Share Analysis 13

4.1.6 Distribution Share Analysis 14

4.1.7 Benchmarking 14

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2456993-brazil-ostomy-procedures-outlook-to-2024

 

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire